BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3948988)

  • 1. [Anti-anginal action of antihypoxants].
    Chichkanov GG; Tsorin IB
    Farmakol Toksikol; 1986; 49(1):52-6. PubMed ID: 3948988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The protective action on the myocardium of antihypoxants in acute occlusion and subsequent reperfusion of the coronary artery].
    Lomtadze DM; Tsorin IB; Chirkova EIu; Chichkanov GG
    Farmakol Toksikol; 1990; 53(2):31-4. PubMed ID: 2369950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of preparations with antihypoxic properties on ischemic damage to the myocardium].
    Tsorin IB; Chichkanov GG
    Biull Eksp Biol Med; 1986 Nov; 102(11):585-7. PubMed ID: 3779087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of antihypoxic agents on the blood supply and function of the intact and ischemic myocardium].
    Chichkanov GG; Tsorin IB
    Farmakol Toksikol; 1985; 48(2):49-54. PubMed ID: 3996570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The long-term use of antihypoxants in myocardial infarct in rats: their effect on the hemodynamics and contractile function of the heart].
    Tsorin IB; Kazanova GV; Chichkanov GG
    Eksp Klin Farmakol; 1993; 56(3):25-7. PubMed ID: 8219984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The absence of a parallelism between the antihypoxic and anti-ischemic actions of pharmacological agents].
    Lomtadze DM; Tsorin IB; Chirkova EIu; Chichkanov GG
    Farmakol Toksikol; 1991; 54(3):27-9. PubMed ID: 1915815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative assessment of the blood supply to the focus of myocardial ischemia in dogs in pharmacological research].
    Matsievskiĭ DD; Lyskovtsev VV; Grigor'eva EK; Zbrizher EA; Chichkanov GG
    Biull Eksp Biol Med; 1988 Nov; 106(11):531-3. PubMed ID: 2973817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of the effect of anti-angina drugs with adrenergic beta receptor agonist action on the collateral hemodynamics and redistribution of the blood flow in chronic myocardial ischemia].
    Chichkanov GG; Bogolepov AK; Matsievskiĭ DD
    Kardiologiia; 1981 Oct; 21(10):85-8. PubMed ID: 6117671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of sodium oxybutyrate on the blood supply and activity of the normal and ischemic myocardium].
    Chichkanov GG; Bogolepov AK; Tsorin IB; Matsievskiĭ DD
    Biull Eksp Biol Med; 1982 Mar; 93(3):44-7. PubMed ID: 7093482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of antianginal agents with a beta-adrenostimulating component of their action on the ischemic myocardium].
    Kaverina NV; Chichkanov GG; Bogolepov AK; Azvolinskaia TN; Matsievskiĭ DD
    Farmakol Toksikol; 1982; 45(4):37-41. PubMed ID: 6127232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological approaches to the therapy of angina.
    Parratt JR
    Adv Drug Res; 1974; 9():103-34. PubMed ID: 4156950
    [No Abstract]   [Full Text] [Related]  

  • 12. [Protective effect of lithium oxybutyrate on the ischemic myocardium].
    Chichkanov GG; Tsorin IB; Kirsanova GIu; Lomtadze DM
    Biull Eksp Biol Med; 1988 Jan; 105(1):46-8. PubMed ID: 3337880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The protective action of vasocyclin (prostacyclin) on the ischemic myocardium].
    Kazanova GV; Tsorin IB; Chirkova EIu; Chichkanov GG
    Farmakol Toksikol; 1991; 54(3):24-7. PubMed ID: 1915814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conservative treatment concepts for stable angina pectoris in coronary heart disease].
    Schoebel FC; Leschke M; Heintzen MP; Strauer BE
    Med Klin (Munich); 1996 Jul; 91(7):458-65. PubMed ID: 8756115
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Collateral coronary blood circulation and its role in the mechanism of the anti-ischemic (antianginal) action of pharmacologic preparations].
    Chichkanov GG; Tsorin IB
    Farmakol Toksikol; 1989; 52(2):15-24. PubMed ID: 2663540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A preclinical evaluation of the antianginal activity of energy metabolism intermediates].
    Kostin VI
    Farmakol Toksikol; 1989; 52(6):49-52. PubMed ID: 2560436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic use of piracetam in myocardial infarct patients].
    Leshchinskiĭ LA; Pimenov LT; Fedorov VS
    Kardiologiia; 1987 Feb; 27(2):46-50. PubMed ID: 3573522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the effect of ethacizin and lidocaine on the blood supply and function of the intact and ischemic myocardium].
    Goldshteĭne GKh; Chichkanov GG
    Biull Eksp Biol Med; 1984 Oct; 98(10):466-9. PubMed ID: 6498326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative study of the effect of nimodipine and flunarizine on the intact and ischemic myocardium].
    Kazanova GV; Kirsanova GIu; Tsorin IB; Chichkanov GG
    Farmakol Toksikol; 1990; 53(3):13-5. PubMed ID: 2387372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.